Dyne Therapeutics, Inc.
Pharmaceutical company · Waltham, Massachusetts, United States · Nasdaq: DYN
Dyne Therapeutics, Inc. is a pharmaceutical company headquartered in Waltham, Massachusetts, United States. Its earliest recorded incorporation is in 2017. Its shares trade on Nasdaq under the ticker DYN. It has reported private securities offerings to the US SEC, most recently $116 million sold in a notice filed in 2020.
Dyne Therapeutics at a glance
What does Dyne Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $115.7 million sold (2020).
Frequently asked questions about Dyne Therapeutics
Where is Dyne Therapeutics headquartered?
Dyne Therapeutics, Inc. is headquartered in Waltham, Massachusetts, United States.
What does Dyne Therapeutics do?
Dyne Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Dyne Therapeutics a public company?
Yes. Dyne Therapeutics, Inc. trades on Nasdaq under the ticker DYN.
When was Dyne Therapeutics founded?
The earliest incorporation on record for Dyne Therapeutics, Inc. is in 2017, according to public company registers.
Similar companies
- Mustang Bio, Inc.Waltham, Massachusetts, United States
- Alkermes IncWaltham, Massachusetts, United States
- Spyre Therapeutics, Inc.Waltham, Massachusetts, United States
- Cogent Biosciences, Inc.Waltham, Massachusetts, United States
- Viridian Therapeutics, Inc.\DEWaltham, Massachusetts, United States
- Korsana Biosciences, Inc.Waltham, Massachusetts, United States
- Jade Biosciences, Inc.Waltham, Massachusetts, United States
- Werewolf Therapeutics, Inc.Waltham, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.